Scarica l'app Stockscreener
6.915
5.41%
-0.415
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché LFST Giù?
Forum
Previsione
Precedente Chiudi:
$7.33
Aprire:
$7.16
Volume 24 ore:
607.35K
Relative Volume:
0.28
Capitalizzazione di mercato:
$2.70B
Reddito:
$1.21B
Utile/perdita netta:
$-95.29M
Rapporto P/E:
-26.60
EPS:
-0.26
Flusso di cassa netto:
$35.06M
1 W Prestazione:
-0.38%
1M Prestazione:
+6.02%
6M Prestazione:
+29.11%
1 anno Prestazione:
-15.03%
Intervallo 1D:
$6.87
$7.235
Intervallo di 1 settimana:
$6.82
$7.415
Portata 52W:
$3.74
$8.095
Lifestance Health Group Inc Stock (LFST) Company Profile
Nome
Lifestance Health Group Inc
Settore
Industria
Telefono
602-767-2100
Indirizzo
4800 N. SCOTTSDALE ROAD, SCOTTSDALE
Compare LFST vs HCA, THC, FMS, ENSG, UHS
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LFST
Lifestance Health Group Inc
|
6.9165 | 2.86B | 1.21B | -95.29M | 35.06M | -0.26 |
|
HCA
Hca Healthcare Inc
|
528.68 | 121.74B | 75.60B | 7.78B | 7.69B | 28.38 |
|
THC
Tenet Healthcare Corp
|
238.58 | 21.29B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
23.07 | 12.86B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
ENSG
Ensign Group Inc
|
205.72 | 12.32B | 4.11B | 239.98M | 193.10M | 4.12 |
|
UHS
Universal Health Services Inc
|
195.85 | 12.36B | 16.08B | 1.20B | 1.06B | 17.82 |
Lifestance Health Group Inc Stock (LFST) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-11-13 | Iniziato | BMO Capital Markets | Outperform |
| 2025-07-25 | Iniziato | BTIG Research | Buy |
| 2025-05-27 | Aggiornamento | UBS | Neutral → Buy |
| 2025-04-08 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2025-04-03 | Iniziato | Canaccord Genuity | Buy |
| 2024-12-16 | Aggiornamento | Goldman | Neutral → Buy |
| 2024-01-03 | Iniziato | Barclays | Underweight |
| 2023-05-15 | Downgrade | TD Cowen | Outperform → Market Perform |
| 2023-01-06 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-11-07 | Ripresa | Jefferies | Buy |
| 2022-03-17 | Downgrade | UBS | Buy → Neutral |
| 2021-11-09 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-09-10 | Iniziato | Cowen | Outperform |
| 2021-08-16 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-06 | Iniziato | Goldman | Neutral |
| 2021-07-06 | Iniziato | JP Morgan | Overweight |
| 2021-07-06 | Iniziato | Jefferies | Buy |
| 2021-07-06 | Iniziato | Morgan Stanley | Overweight |
| 2021-07-06 | Iniziato | William Blair | Outperform |
Mostra tutto
Lifestance Health Group Inc Borsa (LFST) Ultime notizie
LifeStance Health Group (NASDAQ:LFST) Director Darren Black Sells 4,314,939 Shares - MarketBeat
Large TPG vehicle trims LifeStance (LFST) stake with 20.7M-share sale - Stock Titan
LifeStance (LFST) Q4 2025 Earnings Call Transcript - AOL.com
LFST Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
AustralianSuper Pty Ltd Makes New $17.06 Million Investment in LifeStance Health Group, Inc. $LFST - MarketBeat
LifeStance Health Group, Inc. (LFST) Stock Analysis: A 36% Potential Upside Beckons Investors - DirectorsTalk Interviews
Lifestance Health Announces Secondary Offering and Share Repurchase - TipRanks
LifeStance Health Group agrees to repurchase 7M shares, underwritten offering totals 25M shares - TradingView
[8-K] LifeStance Health Group, Inc. Reports Material Event | LFST SEC FilingForm 8-K - Stock Titan
Should LifeStance Health’s Profit Turnaround And Capital Moves Require Action From LifeStance Health Group (LFST) Investors? - Yahoo Finance
LifeStance Health Group (LFST) Profit Turn Challenges Skeptical Earnings Narratives - Sahm
Canaccord Lifts PT on LifeStance Health Group (LFST) to $10 From $9, Here's Why - Finviz
Canaccord Lifts PT on LifeStance Health Group (LFST) to $10 From $9, Here’s Why - Yahoo Finance
LifeStance (NASDAQ: LFST) selling stockholders register 25M shares; Company to repurchase 7M - Stock Titan
KeyBanc raises Lifestance Health stock price target on productivity By Investing.com - Investing.com Australia
Canaccord Genuity Group Forecasts Strong Price Appreciation for LifeStance Health Group (NASDAQ:LFST) Stock - MarketBeat
LifeStance Health Group (NASDAQ:LFST) Releases Quarterly Earnings Results, Misses Estimates By $0.02 EPS - MarketBeat
Key facts: LifeStance Health posts $24.1M profit; announces share offering - TradingView
6 Analysts Assess LifeStance Health Gr: What You Need To Know - Benzinga
LifeStance Health Group (NASDAQ:LFST) Stock Price Expected to Rise, UBS Group Analyst Says - MarketBeat
LifeStance Health Group (NASDAQ:LFST) Sees Strong Trading Volume on Analyst Upgrade - MarketBeat
UBS Adjusts Price Target on Lifestance Health Group to $12 From $10, Maintains Buy Rating - marketscreener.com
LifeStance Health Group (NASDAQ:LFST) Price Target Raised to $9.00 - MarketBeat
LifeStance Health Group, Inc. (NASDAQ:LFST) Q4 2025 Earnings Call Transcript - Insider Monkey
LifeStance stockholders plan 25M share offering By Investing.com - Investing.com India
KeyBanc raises Lifestance Health stock price target on productivity - Investing.com India
Decoding LifeStance Health Group Inc (LFST): A Strategic SWOT In - GuruFocus
LifeStance Health Group, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:LFST) 2026-02-26 - Seeking Alpha
Earnings call transcript: LifeStance Health beats Q4 2025 expectations, stock surges - Investing.com Australia
Lifestance Health Group announces launch of secondary public offering - marketscreener.com
LifeStance Health Group (NASDAQ:LFST) Initiates Share Repurchase Program - MarketBeat
LifeStance Health Q4 2025 slides: revenue beats, EBITDA soars 49% By Investing.com - Investing.com Australia
LifeStance Health Q4 2025 Results: Profit and Revenue Beat EstimatesNews and Statistics - IndexBox
BMO Maintains Outperform on LFST LifeStance Health Group Feb 2026, PT $10 - Meyka
Lifestance Health Group Announces Launch Of Secondary Public Offering - TradingView
LifeStance stockholders plan 25M share offering - Investing.com
LifeStance CEO: Large Mental Health Company Valuations are ‘Dislocated from Reality’ - Behavioral Health Business
LifeStance Health Group Announces Launch of Secondary Public Offering - The Manila Times
Existing LifeStance investors to sell 25M shares as company buys back 7M - Stock Titan
LifeStance Health Group Q4 Earnings Call Highlights - MarketBeat
LFST SEC FilingsLifestance Health Group, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Key facts: LifeStance Health reports 14% revenue growth; Burdick named Non-Executive Chairman - TradingView
LifeStance Health Group (NASDAQ:LFST) Shares Gap UpStill a Buy? - MarketBeat
LifeStance Health Group Q4 2025 Earnings Call Transcript - MarketBeat
LifeStance Health : Q4 2025 Earnings Script - marketscreener.com
LifeStance Health Group, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
LifeStance Health Group (LFST) Q4 Earnings and Revenues Top Estimates - Yahoo Finance
LifeStance Health Q4 2025 slides: revenue beats, EBITDA soars 49% - Investing.com
LifeStance Health Group, Inc. announces an Equity Buyback for $100 million worth of its shares. - marketscreener.com
LifeStance Health Group (NASDAQ:LFST) Posts Better-Than-Expected Sales In Q4 CY2025, Stock Jumps 12.7% - Finviz
Earnings Summary: LifeStance Health Gr Q4 - Benzinga
Lifestance Health Group Inc Azioni (LFST) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Lifestance Health Group Inc Azioni (LFST) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| BLACK DARREN M. | Director |
Mar 02 '26 |
Sale |
7.01 |
4,314,939 |
30,247,722 |
29,209,776 |
| Bessler Robert | Director |
Dec 19 '25 |
Sale |
7.04 |
119,942 |
844,392 |
1,318,983 |
| Bessler Robert | Director |
Dec 22 '25 |
Sale |
7.04 |
1,701 |
11,975 |
1,318,133 |
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):